Status:
COMPLETED
Efficacy Assessment of SCENAR Device on Common Spinal Pain Syndrome
Lead Sponsor:
Hopital Foch
Conditions:
Pain Syndrome
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Randomized, singled blinded, controlled trial of the efficacy of a SCENAR session in patients with vertebral pain. SCENAR is an electrotherapy device.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Male or female over 18 and under 80 years of age
- Suffering of common spinal pain: cervical pain including cervico-brachial neuralgia, lumbar pain including lumbo-radiculalgia
- Having attended a "pain consultation" or referred to a pain consultant during hospitalization
- Having signed the consent form
- Can be contacted directly by phone if patient is not hospitalized
- Be affiliated to a national insurance scheme or benefiting from such a program
- Non-inclusion Criteria:
- Pregnant or breast-feeding women
- Patients with a pacemaker
- Patients whose skin condition makes the use of SCENAR impossible (wounds, recent scars, skin infections)
- Patient whose spinal pain is known to be related to inflammatory pathology (spondylarthropathy, rheumatoid arthritis, chondrocalcinosis), trauma (fractures and dislocations), tumor (metastases, myeloma localization), spondylodiscitis infectious, neurological (intrarachidian tumor or posterior fossa) or radiculalgia with deficient signs
- Patients who have already had a SCENAR session
- Patients who have already participated in this study
Exclusion
Key Trial Info
Start Date :
November 14 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 21 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03755817
Start Date
November 14 2018
End Date
November 21 2020
Last Update
January 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Foch
Suresnes, France, 92150